Russia is expanding trials of a vaccine against Covid-19 which may start production soon

With Russia’s intention to register what it describes as the first vaccine in the world against the Covid-19 disease which is causing the Coronavirus, medical workers and municipal council employees in the capital, Moscow, have had the opportunity to receive vaccination against the virus, according to Bloomberg news agency, on Thursday.

Bloomberg said that according to one of the doctors who received the offer, at least one hospital is preparing to prepare a list of workers who want to receive the vaccine developed by the Gamaleya Institute in Moscow.

A city council official said that similar invitations were sent to employees there, asking for volunteers to receive vaccination.

The invitation, seen by Bloomberg, affirms that the vaccine is safe and has undergone clinical trials. 

The press office of the Moscow City Council declined to comment on the report.

Deputy Prime Minister Tatyana Golikova told President Vladimir Putin at a meeting on July 29 that the Gamaleya vaccine, which is being developed in cooperation with the Russian Direct Investment Fund, is expected to receive a conditional license this month, as it requires trials on 1,600 people.

Others, and it will likely start production in September.